CNMD FY 2018 Earnings Report — CONMED Corporation Revenue & Financial Results | Market Cap Arena

CONMED CorporationCNMD

FY 2018 Earnings

Reported February 25, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$860M	—	$796M	—	7.9%
Op. Income	$71M	—	$47M	—	51.9%
Gross Margin	54.6%	—	54.1%	—	0.4pp
Net Margin	4.8%	—	7.0%	—	-2.2pp
EPS (Diluted)	$1.41	—	$1.97	—	-28.4%
Free Cash Flow	$58M	—	$53M	—	10.4%

Revenue Flow

Item	Amount
REVENUE	$860M
Cost of Revenue	$391M
GROSS PROFIT	$469M
R&D Expenses	$42M
Selling & Marketing	$0
General & Administrative	$356M
SG&A Expenses	$356M
Other Expenses	$0
Operating Expenses	$398M
Cost & Expenses	$788M
OPERATING INCOME	$71M
Interest Income	$0
Interest Expense	$21M
Other Income/Expenses	-$21M
INCOME BEFORE TAX	$51M
Income Tax Expense	$10M
Net Income from Continuing Ops	$41M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$41M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$41M
D&A	$62M
EBIT	$71M
EBITDA	$133M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$860M
Cost of Revenue	$391M
GROSS PROFIT	$469M
R&D Expenses	$42M
Selling & Marketing	$0
General & Administrative	$356M
SG&A Expenses	$356M
Other Expenses	$0
Operating Expenses	$398M
Cost & Expenses	$788M
OPERATING INCOME	$71M
Interest Income	$0
Interest Expense	$21M
Other Income/Expenses	-$21M
INCOME BEFORE TAX	$51M
Income Tax Expense	$10M
Net Income from Continuing Ops	$41M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$41M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$41M
D&A	$62M
EBIT	$71M
EBITDA	$133M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$41M
Depreciation & Amortization	$62M
Stock-Based Compensation	$10M
Deferred Income Tax	$2M
Other Non-Cash Items	$4M
Change in Working Capital	-$44M
OPERATING CASH FLOW	$75M
Capital Expenditure	-$17M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$17M
Net Debt Issuance	-$30M
Common Stock Repurchased	$0
Common Dividends Paid	-$22M
Other Financing Activities	-$20M
NET CASH FROM FINANCING	-$72M
FREE CASH FLOW	$58M
Net Change in Cash	-$15M

Balance Sheet

Item	Amount
Cash & Equivalents	$18M
Short-Term Investments	$0
Net Receivables	$182M
Inventory	$155M
Other Current Assets	$5M
TOTAL CURRENT ASSETS	$374M
PP&E (Net)	$113M
Goodwill	$400M
Intangible Assets	$413M
Long-Term Investments	$0
Tax Assets	$5M
Other Non-Current Assets	$63M
TOTAL NON-CURRENT ASSETS	$995M
TOTAL ASSETS	$1.4B
Account Payables	$53M
Short-Term Debt	$18M
Deferred Revenue	$43M
Other Current Liabilities	$46M
TOTAL CURRENT LIABILITIES	$161M
Long-Term Debt	$439M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$81M
Other Non-Current Liabilities	$26M
TOTAL NON-CURRENT LIABILITIES	$546M
TOTAL LIABILITIES	$707M
Common Stock	$313.0K
Additional Paid-In Capital	$342M
Retained Earnings	$465M
Treasury Stock	-$89M
Accum. Other Comp. Income	-$56M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$662M
Minority Interest	$0
TOTAL EQUITY	$662M
TOTAL LIABILITIES & EQUITY	$1.4B
Total Debt	$457M
Net Debt	$439M